BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16922340)

  • 1. [Osteoporosis and gynecology].
    Damianov L; Damianova V; Dolapchiev V
    Akush Ginekol (Sofiia); 2006; 45 Suppl 2():16-8. PubMed ID: 16922340
    [No Abstract]   [Full Text] [Related]  

  • 2. A more active role for gynecologists in the prevention of postmenopausal osteoporosis.
    Ylikorkala O
    Gynecol Endocrinol; 2008 Jun; 24(6):293-4. PubMed ID: 18584406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bone densitometry and hormone therapy].
    Rizk P
    Pathol Biol (Paris); 1998 May; 46(5):291-3. PubMed ID: 9769887
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteoporosis: handy tools for detection, helpful tips for treatment.
    Morgan SL; Kitchin B
    J Fam Pract; 2008 May; 57(5):311-20. PubMed ID: 18460296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Osteoporosis from the gynecologic viewpoint].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1992; 114(7):333-50. PubMed ID: 1509831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis. Guarding against bone loss now and in the future.
    Mayo Clin Womens Healthsource; 2006 Jul; Suppl():1-8. PubMed ID: 16741492
    [No Abstract]   [Full Text] [Related]  

  • 7. Estrogens and osteoporosis.
    Ribot C; Trémollières F
    Rev Rhum Engl Ed; 1998 Nov; 65(11):641-8. PubMed ID: 9850533
    [No Abstract]   [Full Text] [Related]  

  • 8. ["European Guidance 2008" for the diagnosis and management of postmenopausal osteoporosis--what is new and clinically relevant?].
    Bartl R;
    Dtsch Med Wochenschr; 2009 Jan; 134(3):92-4. PubMed ID: 19142840
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
    Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM
    J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of aromatase inhibitors on bone metabolism].
    Folkestad L; Bjerregaard JK; Bjarnason NH; Brixen KT
    Ugeskr Laeger; 2007 May; 169(19):1774-9. PubMed ID: 17537350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management of osteoporosis.
    Fontenot HB; Harris AL
    J Obstet Gynecol Neonatal Nurs; 2014; 43(2):236-45; quiz E20-1. PubMed ID: 24502394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate addition to stable hormone replacement therapy increases bone mineral density in postmenopausal women.
    Boulos P; Sebaldt RJ; Goldsmith CH
    J Rheumatol; 2002 May; 29(5):1110-1. PubMed ID: 12022339
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors.
    Clunie GP; Clark A; Mortimer CJ; Stephenson S; Aitken J; Smith C; Sherwin E; Archer TJ
    Eur J Surg Oncol; 2009 May; 35(5):475-80. PubMed ID: 18950981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rise of raloxifene and the fall of invasive breast cancer.
    Jordan VC
    J Natl Cancer Inst; 2008 Jun; 100(12):831-3. PubMed ID: 18544739
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogen replacement therapy in osteoporosis].
    Hirvonen E
    Duodecim; 1996; 112(22):2123-9. PubMed ID: 10605218
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy and osteoporosis.
    Drury R
    Ir Med J; 1997 Oct; 90(6):214, 216. PubMed ID: 9611918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postmenopausal risk of osteoporosis].
    Concin H; Taxer F; Maier R; Sader E
    Gynakol Rundsch; 1989; 29 Suppl 2():472-3. PubMed ID: 2613079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.